Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases
This study is ongoing, but not recruiting participants.
Study NCT00542048   Information provided by MediGene
First Received: October 9, 2007   Last Updated: August 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Cancer
Neoplasm Metastasis
Additional conditions recognized in this trial
Liver Neoplasms
Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
EndoTAG®-1
Sponsors listed in this trial
MediGene


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services